Qiagen grounds drug discovery AI agents in curated knowledge

Qiagen's Discovery Platform anchors drug discovery AI agents in biomedical data manually curated by over 150 MD- and PhD-level experts for more than 25 years. The platform adds Model Context Protocol access and an agentic Discovery Explorer, building on a May partnership with Nvidia on graph-based AI.

• Biomedical data curated by hand by 150+ MD and PhD experts
• Platform layers MCP access and agentic Discovery Explorer
• Qiagen and Nvidia teamed up in May on graph-based AI
• Goal is traceable outputs without agent hallucinations